These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14513964)

  • 1. Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation.
    Lee L; Daughton S; Scheer S; Stemple JC; Weinrich B; Miller-Seiler T; Goeller S; Levin L
    J Voice; 2003 Sep; 17(3):411-24. PubMed ID: 14513964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
    Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
    J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical investigations of adductor spastic dysphonia.
    Hartman DE; Abbs JH; Vishwanat B
    Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):247-52. PubMed ID: 3377392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
    Morzaria S; Damrose EJ
    J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Examination of Pre- and Posttreatment Acoustic Versus Auditory Perceptual Analyses of Voice Across Four Common Voice Disorders.
    Gillespie AI; Gartner-Schmidt J; Lewandowski A; Awan SN
    J Voice; 2018 Mar; 32(2):169-176. PubMed ID: 28688672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of Voice Therapy: A Primary Investigation of Voice Outcomes for Surgical Benign Vocal Fold Lesion Patients.
    Tang SS; Thibeault SL
    J Voice; 2017 Jan; 31(1):129.e1-129.e7. PubMed ID: 26776951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
    Ludlow CL; Naunton RF; Terada S; Anderson BJ
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voice handicap index results for older patients with adductor spasmodic dysphonia.
    Wingate JM; Ruddy BH; Lundy DS; Lehman J; Casiano R; Collins SP; Woodson GE; Sapienza C
    J Voice; 2005 Mar; 19(1):124-31. PubMed ID: 15766857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technique for injection of botulinum toxin through the flexible nasolaryngoscope.
    Rhew K; Fiedler DA; Ludlow CL
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):787-94. PubMed ID: 7991260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia.
    Green DC; Berke GS; Ward PH; Gerratt BR
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):883-7. PubMed ID: 1444094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia.
    Van Pelt F; Ludlow CL; Smith PJ
    Ann Otol Rhinol Laryngol; 1994 Mar; 103(3):192-200. PubMed ID: 8122835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
    Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
    Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of VHI-10 to voice laboratory measurements across five common voice disorders.
    Gillespie AI; Gooding W; Rosen C; Gartner-Schmidt J
    J Voice; 2014 Jul; 28(4):440-8. PubMed ID: 24698885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
    Mendelsohn AH; Berke GS
    Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.